EMEA-001146-PIP01-11-M07
Key facts
Invented name |
Moventig
|
Active substance |
Naloxegol
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0493/2021
|
PIP number |
EMEA-001146-PIP01-11-M07
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of opioid-induced constipation
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Kyowa Kirin Pharmaceutical Development Limited
Tel. +44 1896664000 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|